Novel determination of caffeine in human urine by direct analysis in real time mass spectrometry

References

• Ziebell, J.; Shaw-Stiffel, T. Update on the Use of Metabolic Probes to Quantify Liver Function: Caffeine versus Lidocaine. Digest. Dis. 1995, 13(14), 239–250.
   PubMed Web of Science ®Google Scholar
• Frederick, W.L.; Willian, G.R. Caffeine Clearance in Cirrhosis: The Value of Simplified Determinations of Liver Metabolic Capacity. J. Hepatol. 1992, 14(2–3), 157–162.
   PubMed Web of Science ®Google Scholar
• Jover, R.; Carnicer, F.; Sanchez-Paya, J.; Climent, E.; Sirvent, M.; Marco, J.L. Salivary Caffeine Clearance Predicts Survival in Patients with Liver Cirrhosis. Am. J. Gastroenterol. 1997, 92(10), 1905–1908.
   PubMed Web of Science ®Google Scholar
• Carrillo, J.A.; Christensen, M.; Ramos, S.I.; Alm, Christina.; Dahl, Marja-Liisa.; Benitez, Julio.; Bertilsson, Leif. Evaluation of Caffeine as an in vivo Probe for CYP1A2 using Measurement in Plasma, Saliva, and Urine. Ther. Drug. Monit. 2000, 22(4), 409–417.
   PubMed Web of Science ®Google Scholar
• Marie-Sophie, C.; Blandine, C.; Jean-Louis, B. Determination of Urinary 13C-Caffeine Metabolites by Liquid Chromatography–Mass Spectrometry: The Use of Metabolic Ratios to Assess CYP1A2 Activity. J. Pharmaceut. Biomed. 2004, 34(2), 379–389.
   PubMed Web of Science ®Google Scholar
• Wen-jie, J.; Yi-li, W.; Xiu-bo, J. Coffee and Caffeine Intake and Breast Cancer Risk: An Updated Dose–Esponse Meta-analysis of 37 Published Studies. Gynecol. Oncol. 2013, 129(3), 620–629.
   PubMed Web of Science ®Google Scholar
• Shi-jin, H.; Hong, X.; Wei, W. Correlation between Caffeine and Risk of Endometrial Cancer: A Meta-Analysis. Chin. J. Evid-based. Med. 2013, 13(3), 313–319.
   Google Scholar
• Renata, V.A.; Silva-Oliveira, E.M.; Márcio, F.; Dutra, M.; Grace, S.P.; Moraes-Santos, T. Chronic Coffee and Caffeine Ingestion Effects on the Cognitive Function and Antioxidant System of Rat Brains. Pharmacol, Biochem. Behav. 2011, 99(4), 659–664.
   PubMed Web of Science ®Google Scholar
• Rivera-Oliver, M.; Díaz-Ríos, M. Using Caffeine and Other Adenosine Receptor Antagonists and Agonists as Therapeutic Tools against Neurodegenerative Diseases: A Review. Life. Sci. 2014, 102(1–2), 1–9.
   PubMed Web of Science ®Google Scholar
• Cyril, L.; Sabiha, E.; Maxime, D.; Antoine, L.; Dominique, D.; Sébastien, C.; Marion, S.; Malika, H.; Christa, E.M.; Luc, B.; David, B. Beneficial Effects of Caffeine in a Transgenic Model of Alzheimer’s Disease-like Tau Pathology. Neurobiol. Aging. 2014, 35(9), 2079–2090.
   PubMed Web of Science ®Google Scholar
• Rômulo, P.B.; Mauren, A.S.; Guilherme, P.A.; Silvio, T.S.; Guilherme, B.; Michele, R.F.; Félix Alexandre, A.S.; Nilda, V.B. Caffeine Supplementation Modulates Oxidative Stressmarkers in the Liver of Trained Rats. Life. Sci. 2014, 96(1–2), 40–45.
   PubMed Web of Science ®Google Scholar
• Kelly, S.F.; Jossimara, P.; Marcos, C.D.; Maria, A.M.R.; Luis, F.B. Prevention of Rat Liver Fibrosis and Carcinogenesis by Coffee and Caffeine. Food Chem. Toxicol. 2014, 64, 20–26.
   PubMed Web of Science ®Google Scholar
• Pragalathan, N.; Shahidul, I. Development of an Alternative Non-Obese Non-Genetic Rat Model of Type 2 Diabetes using Caffeine and Streptozotocin. Pharmacol. Rep. 2014, 66(4), 585–593.
   PubMed Web of Science ®Google Scholar
• Kazuaki, S.; Junji, O.; Ryoko, O.; Hideyuki, I.; Takashi, Y.; Chiaki, K. Effects of Chlorogenic Acid and its Metabolites on the Sleep-Wakefulness Cycle in Rats. Eur. J. Pharmacol. 2004, 504(3), 185–189.
   PubMed Web of Science ®Google Scholar
• John, P.H.; Kavita, M.B. Caffeine Reduces Myocardial Blood Flow During Exercise. Am. J. Med. 2013, 126(8), 730.e1–730.e8.
   Google Scholar
• Winkelmayer, W.C.; Stampfer, M.J.; Willett, W.C.; Curhan, G.C. Habitual Caffeine Intake and the Risk of Hypertension in Women. J. Am. Med. Assoc. 2005, 294(18), 2330–2335.
   Web of Science ®Google Scholar
• Mathias, P; Antoine, K.; Bruno, L.; Nicolas, G.; Frederic, D.; Emmanuel, P.; Jean-François, P.; Bruno, C. Fatal Cardiac Arrhythmia Following Voluntary Caffeine Overdose in an Amateur Body-Builder Athlete. Int. J. Cardiol. 2013, 166(3), e41–e42.
   PubMed Web of Science ®Google Scholar
• Raj, M.A.; Abraham, J.S. Simultaneous Determination of Uric Acid, Xanthine, Hypoxanthine and Caffeine in Human Blood Serum and Urine Samples using Electrochemically Reduced Graphene Oxide Modified Electrode. Anal. Chim. Acta. 2013, 771, 14–20.
   PubMed Web of Science ®Google Scholar
• L’ubomir, Š.; Peter, T.; Jana, S.; Miroslav, R.; Dušan, B. Voltammetric Determination of Caffeine in Beverage Samples on Bare Boron-Doped Diamond Electrode. Food Chem. 2012, 135(3), 1198–1204.
   PubMed Web of Science ®Google Scholar
• Salinas-Vargas, M.E.; Canizares-Macias, M.P. On-line Solid–Phase Extraction using a C18 Minicolumn Coupled to a Flow Injection System for Determination of Caffeine in Green and Roasted Coffee Beans. Food Chem. 2014, 147, 182–188.
   PubMed Web of Science ®Google Scholar
• Ghada, M.H.; Randa, A.A.; Rabab, M.S.; Mostafa, K.M. Rapid and Simultaneous Determination of Antioxidant Markers and Caffeine in Commercial Teas and Dietary Supplements by HPLC-DAD. Talanta 2012, 101, 38–44.
   PubMed Web of Science ®Google Scholar
• Marie-Sophie, C.; Walid, E.; Marie-Claude, D; Jean-Louis, B. Analysis of Urinary Caffeine Metabolites by HPLC-DAD: The Use of Metabolic Ratios to Assess CYP1A2 Enzyme Activity. J. Pharmaceut. Biomed. 2002, 27(1–2), 261–270.
   PubMed Web of Science ®Google Scholar
• Jun, X.; Jie, C.; Man, H.; Bin, Hu. Simultaneous Quantification of Amphetamines, Caffeine and Ketamine in Urine by Hollow Fiber Liquid Phase Microextraction Combined with Gas Chromatography-Flame Ionization Detector. Talanta 2010, 82(3), 969–975.
   PubMed Web of Science ®Google Scholar
• Hassan, S.; Soheila, S. A Rapid and Simple Determination of Caffeine in Teas, Coffees and Eight Beverages. Food Chem. 2014, 158, 8–13.
   PubMed Web of Science ®Google Scholar
• Jafari, M.T.; Rezaei, B.; Javaheri, M. A New Method based on Electrospray Ionisation Ion Mobility Spectrometry (ESI-IMS) for Simultaneous Determination of Caffeine and Theophylline. Food Chem. 2011, 126(4), 1964–1970.
   PubMed Web of Science ®Google Scholar
• Alexander, J.; Kinzig-Schippers, M.; Michael, I.; Robert, H.; Katharina, E.; Jurgen, B.; Helga, W.; Gillian, S.; Ingolf, C.; Fritz, S.; Uwe, F. Phenotyping of N-acetyltransferase Type 2 by Caffeine from Uncontrolled Dietary Exposure. Eur. J. Clin. Pharmacol. 2004, 60(1), 17–21.
   PubMed Web of Science ®Google Scholar
• Li, J; Xiang-qian, P.; Zhang, J.; Ji-ping, X. Determination of the Activity of Cytochrome P450 CYP2A6 by HPLC Method with Caffeine as Metabolizing Probe. Acta Pharmaceutica Sinica 2006, 41(3), 282–284.
   PubMedGoogle Scholar
• Yu-qiao, S.; Jie, L.; Cheng, Z.; Bin, W.; Charles, C.L. A Novel Approach to Determine Tyrosine in Human Plasma by DART-MS/MS. Analyt. Meth. 2015, 7(4), 1600–1605.
   Web of Science ®Google Scholar
• Adam, S.P.; Emma, T.; Arjun, T.; Sami Rifai; Mark, K. Quantification of Theobromine and Caffeine in Saliva, Plasma and Urine via Liquid Chromatography –Tandem Mass Spectrometry: A Single Analytical Protocol Applicable to Cocoa Intervention Studies. J. Chromatogr. B 2010, 878(3–4), 409–416.
   PubMed Web of Science ®Google Scholar
• Martínez-López, S.; Beatriz, S.; Gema, B.; Raquel, M.; Bravo-Clemente, L. Pharmacokinetics of Caffeine and its Metabolites in Plasma and Urine after Consuming a Soluble Green/Roasted Coffee Blend by Healthy Subjects. Food. Res. Int. 2014, 64, 125–133.
   Web of Science ®Google Scholar